Contact Form

Name

Email *

Message *

Cari Blog Ini

Image

Choroba Eb An In Depth Guide


Choroba Eb

Choroba Eb: An In-Depth Guide

What is Choroba Eb?

Choroba Eb, also known as congenital erythropoietic porphyria (CEP), is a rare genetic disorder that affects the production of hemoglobin, the oxygen-carrying protein in red blood cells. It is caused by mutations in the gene that encodes the enzyme uroporphyrinogen III synthase (UROS), which is necessary for the production of heme, the iron-containing component of hemoglobin.

Symptoms of Choroba Eb

The symptoms of Choroba Eb vary depending on the severity of the condition. Mild cases may only experience skin sensitivity to sunlight, while more severe cases can have life-threatening complications such as anemia, liver damage, and neurological problems.

Common symptoms include:

  • Skin sensitivity to sunlight
  • Blistering and scarring of the skin
  • Red or brown urine
  • Anemia
  • Fatigue
  • Abdominal pain
  • Liver damage
  • Neurological problems

Causes of Choroba Eb

Choroba Eb is caused by mutations in the UROS gene. This gene encodes the enzyme uroporphyrinogen III synthase, which is necessary for the production of heme. Mutations in this gene can lead to a deficiency of UROS enzyme, which can result in a buildup of porphyrins, the precursors to heme.

Treatment for Choroba Eb

There is no cure for Choroba Eb, but treatment can help to manage the symptoms and prevent complications. Treatment may include:

Photoprotection

*

Avoiding sun exposure

*

Wearing protective clothing and sunscreen

Blood transfusions

*

To treat anemia

Chelation therapy

*

To remove excess porphyrins from the body

Liver transplant

*

In severe cases, to treat liver damage

Prognosis for Choroba Eb

The prognosis for Choroba Eb varies depending on the severity of the condition. Mild cases may have a normal life expectancy, while more severe cases may have a shortened life expectancy. With proper treatment, most people with Choroba Eb can live a full and active life.

Additional Resources


Comments